Reuters logo
BRIEF-Actinium Pharmaceuticals granted orphan designation for Iomab-B
2016年10月18日 / 上午11点22分 / 1 年前

BRIEF-Actinium Pharmaceuticals granted orphan designation for Iomab-B

Oct 18 (Reuters) - Actinium Pharmaceuticals Inc :

* Actinium Pharmaceuticals granted orphan designation from the European Medicines Agency for Iomab-B Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below